• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国州级堕胎限制与 COVID-19 大流行早期药物流产服务创新的关联。

The association of U.S. state-level abortion restrictions with medication abortion service delivery innovations during the early COVID-19 pandemic.

机构信息

Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Planned Parenthood League of Massachusetts, Boston, MA, United States.

Planned Parenthood League of Massachusetts, Boston, MA, United States; Heller School for Social Policy and Management, Brandeis University, Waltham, MA, United States.

出版信息

Contraception. 2022 Sep;113:26-29. doi: 10.1016/j.contraception.2022.04.003. Epub 2022 Apr 14.

DOI:10.1016/j.contraception.2022.04.003
PMID:35430237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9010011/
Abstract

OBJECTIVES

To assess whether state-level abortion restrictions resulted in differential uptake of innovative medication abortion practices such as changing ultrasound requirements, offering telehealth, or dispensing medications without a physical exam during the early COVID-19 pandemic.

METHODS

We used data from a prospective national survey of abortion providers to assess the association between a novel index of state-level abortion hostility and adoption of medication abortion services innovations during the pandemic.

RESULTS

Clinics in states with low or medium hostility were more likely to adopt innovative practices than those in high or extreme hostility states.

CONCLUSIONS

Clinics in abortion hostile states were less likely to adopt clinical recommendations and public health best practices for abortion care during the COVID-19 pandemic.

摘要

目的

评估州级堕胎限制是否导致创新性药物流产实践(如改变超声要求、提供远程医疗或在 COVID-19 大流行期间无需体检即可配药)的采用存在差异。

方法

我们使用一项针对堕胎提供者的前瞻性全国性调查的数据,评估了一种新型州级堕胎敌对指数与大流行期间药物流产服务创新采用之间的关联。

结果

与高敌对或极敌对州的诊所相比,敌对程度低或中等的州的诊所更有可能采用创新实践。

结论

在 COVID-19 大流行期间,堕胎敌对州的诊所不太可能采用堕胎护理的临床建议和公共卫生最佳实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a654/9010011/f7363b4ac4f9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a654/9010011/f7363b4ac4f9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a654/9010011/f7363b4ac4f9/gr1_lrg.jpg

相似文献

1
The association of U.S. state-level abortion restrictions with medication abortion service delivery innovations during the early COVID-19 pandemic.美国州级堕胎限制与 COVID-19 大流行早期药物流产服务创新的关联。
Contraception. 2022 Sep;113:26-29. doi: 10.1016/j.contraception.2022.04.003. Epub 2022 Apr 14.
2
Abortion services during the COVID-19 pandemic: a systematic review.COVID-19 大流行期间的堕胎服务:系统评价。
Reprod Health. 2023 Apr 13;20(1):61. doi: 10.1186/s12978-023-01582-3.
3
Remote Delivery in Reproductive Health Care: Operation of Direct-to-Patient Telehealth Medication Abortion Services in Diverse Settings.远程生殖保健服务:不同环境下直接面向患者的远程医疗药物流产服务的运作。
Ann Fam Med. 2022 Jul-Aug;20(4):336-342. doi: 10.1370/afm.2821. Epub 2022 Jul 13.
4
Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic.在 COVID-19 大流行期间,俄亥俄州、肯塔基州和西弗吉尼亚州在扩大药物和远程医疗堕胎服务方面面临联邦、州和机构障碍。
Contraception. 2021 Jul;104(1):111-116. doi: 10.1016/j.contraception.2021.04.020. Epub 2021 Apr 27.
5
The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.加拿大医疗保健专业人员对 COVID-19 大流行期间堕胎服务的看法。
Fam Pract. 2021 Aug 27;38(Suppl 1):i30-i36. doi: 10.1093/fampra/cmab083.
6
Changes to medication abortion clinical practices in response to the COVID-19 pandemic.药物流产临床实践因应 COVID-19 大流行而作出的改变。
Contraception. 2021 Jul;104(1):77-81. doi: 10.1016/j.contraception.2021.04.010. Epub 2021 Apr 21.
7
Comparing hospital- vs. non-hospital-affiliated clinic adoption of abortion innovations and cash-pay availability during the COVID-19 pandemic: A secondary analysis of a United States nationwide survey.比较 COVID-19 大流行期间医院附属诊所与非医院附属诊所对堕胎创新技术的采用情况和现金支付的可获得性:对美国全国性调查的二次分析。
Contraception. 2024 Sep;137:110493. doi: 10.1016/j.contraception.2024.110493. Epub 2024 May 16.
8
COVID-19, health care, and abortion exceptionalism in the United States.美国的 COVID-19、医疗保健和堕胎例外主义。
Perspect Sex Reprod Health. 2021 Mar;53(1-2):5-12. doi: 10.1363/psrh.12182. Epub 2021 Aug 26.
9
Family Physicians' Role in Simplifying Medication Abortion During the COVID-19 Pandemic.家庭医生在 COVID-19 大流行期间简化药物流产的作用。
J Am Board Fam Med. 2021 Feb;34(Suppl):S33-S36. doi: 10.3122/jabfm.2021.S1.200208.
10
The Provision of Abortion Care via Telehealth in the United States: A Rapid Review.美国通过远程医疗提供堕胎护理:快速审查。
J Midwifery Womens Health. 2023 Nov-Dec;68(6):744-758. doi: 10.1111/jmwh.13586. Epub 2023 Dec 9.

引用本文的文献

1
Spatial Disparities in Mifepristone Use for Early Miscarriage and Induced Abortion Among Obstetrician-Gynecologists Practicing in Massachusetts.在马萨诸塞州执业的妇产科医生中,米非司酮用于早期流产和人工流产的空间差异。
Womens Health Rep (New Rochelle). 2024 Oct 4;5(1):765-774. doi: 10.1089/whr.2024.0085. eCollection 2024.

本文引用的文献

1
Abortion Safety and Use with Normally Prescribed Mifepristone in Canada.加拿大正常处方米非司酮的安全性和使用
N Engl J Med. 2022 Jan 6;386(1):57-67. doi: 10.1056/NEJMsa2109779. Epub 2021 Dec 8.
2
Variation in Restrictive Abortion Policies and Adverse Birth Outcomes in the United States from 2005 to 2015.2005年至2015年美国限制性堕胎政策的变化与不良生育结局
Womens Health Issues. 2022 Mar-Apr;32(2):103-113. doi: 10.1016/j.whi.2021.10.006. Epub 2021 Nov 18.
3
State Abortion Policies and Maternal Death in the United States, 2015‒2018.
2015 - 2018年美国各州堕胎政策与孕产妇死亡情况
Am J Public Health. 2021 Sep;111(9):1696-1704. doi: 10.2105/AJPH.2021.306396. Epub 2021 Aug 19.
4
Changes to medication abortion clinical practices in response to the COVID-19 pandemic.药物流产临床实践因应 COVID-19 大流行而作出的改变。
Contraception. 2021 Jul;104(1):77-81. doi: 10.1016/j.contraception.2021.04.010. Epub 2021 Apr 21.
5
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.美国直接面向患者的远程医疗堕胎服务的扩展及 COVID-19 大流行期间的经验。
Contraception. 2021 Jul;104(1):43-48. doi: 10.1016/j.contraception.2021.03.019. Epub 2021 Mar 27.
6
Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study.远程医疗提供的无检测药物流产(终止妊娠)的有效性、安全性和可接受性:一项全国性队列研究。
BJOG. 2021 Aug;128(9):1464-1474. doi: 10.1111/1471-0528.16668. Epub 2021 Mar 24.
7
Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic.COVID-19 大流行期间 12 周妊娠以下的远程医疗药物流产:一项前瞻性观察性队列研究。
BMJ Sex Reprod Health. 2021 Oct;47(4):246-251. doi: 10.1136/bmjsrh-2020-200976. Epub 2021 Feb 4.
8
State and federal abortion restrictions increase risk of COVID-19 exposure by mandating unnecessary clinic visits.州和联邦的堕胎限制通过强制要求不必要的诊所就诊,增加了 COVID-19 暴露的风险。
Contraception. 2020 Dec;102(6):385-391. doi: 10.1016/j.contraception.2020.08.017. Epub 2020 Sep 6.
9
Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.评论:非检测药物流产:大流行期间及之后增加可及性的示例方案。
Contraception. 2020 Jun;101(6):361-366. doi: 10.1016/j.contraception.2020.04.005. Epub 2020 Apr 16.
10
TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.远程人工流产:美国直接面向患者的远程医疗流产服务评估。
Contraception. 2019 Sep;100(3):173-177. doi: 10.1016/j.contraception.2019.05.013. Epub 2019 Jun 4.